A Phase <scp>II</scp> Pilot Study of Anti‐ <scp>PD</scp> ‐ <scp>L1</scp> , Durvalumab, and a <scp>PARP</scp> Inhibitor, Olaparib in Patients With Metastatic Triple‐Negative Breast Cancer With or Without Germline BRCA Mutation
Year: 2025
Type: article
Language: en
Topic: PARP inhibition in cancer therapy
Authors and affiliations:
raw_author_name: Takeo Fujii
raw_affiliation_strings: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Ashley Cimino‐Mathews
raw_affiliation_strings: Department of Pathology The Johns Hopkins University School of Medicine  Baltimore Maryland USA
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
raw_author_name: Stanley Lipkowitz
raw_affiliation_strings: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Min‐Jung Lee
raw_affiliation_strings: Developmental Therapeutic Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Developmental Therapeutic Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Jayakumar Nair
raw_affiliation_strings: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Britanny Brooke Solarz
raw_affiliation_strings: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Alexandra Zimmer
raw_affiliation_strings: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Bernadette Redd
raw_affiliation_strings: Radiology and Imaging Sciences, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Radiology and Imaging Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Elliot B. Levy
raw_affiliation_strings: Radiology and Imaging Sciences, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Radiology and Imaging Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Shraddha Rastogi
raw_affiliation_strings: Developmental Therapeutic Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Developmental Therapeutic Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Nahoko Sato
raw_affiliation_strings: Developmental Therapeutic Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Developmental Therapeutic Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Ann McCoy
raw_affiliation_strings: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Seth M. Steinberg
raw_affiliation_strings: Collaborative Biostatistics Section, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Collaborative Biostatistics Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
raw_author_name: Jung‐Min Lee
raw_affiliation_strings: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute National Institutes of Health  Bethesda Maryland USA
Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA